Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy

Abstract Aims Echocardiographic response after cardiac resynchronization therapy (CRT) is often lesser in ischaemic cardiomyopathy (ICM) than non‐ischaemic dilated cardiomyopathy (NIDCM) patients. We assessed the association of heart failure aetiology on the amount of reverse remodelling and outcome...

Full description

Bibliographic Details
Main Authors: Mariëlle Kloosterman, Antonius M.W. vanStipdonk, Iris terHorst, Michiel Rienstra, Isabelle C. Van Gelder, Marc A. Vos, Frits W. Prinzen, Matthias Meine, Kevin Vernooy, Alexander H. Maass
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.12624
_version_ 1819002973480550400
author Mariëlle Kloosterman
Antonius M.W. vanStipdonk
Iris terHorst
Michiel Rienstra
Isabelle C. Van Gelder
Marc A. Vos
Frits W. Prinzen
Matthias Meine
Kevin Vernooy
Alexander H. Maass
author_facet Mariëlle Kloosterman
Antonius M.W. vanStipdonk
Iris terHorst
Michiel Rienstra
Isabelle C. Van Gelder
Marc A. Vos
Frits W. Prinzen
Matthias Meine
Kevin Vernooy
Alexander H. Maass
author_sort Mariëlle Kloosterman
collection DOAJ
description Abstract Aims Echocardiographic response after cardiac resynchronization therapy (CRT) is often lesser in ischaemic cardiomyopathy (ICM) than non‐ischaemic dilated cardiomyopathy (NIDCM) patients. We assessed the association of heart failure aetiology on the amount of reverse remodelling and outcome of CRT. Methods and results Nine hundred twenty‐eight CRT patients were retrospectively included. Reverse remodelling and endpoint occurrence (all‐cause mortality, heart transplantation, or left ventricular assist device implantation) was assessed. Two response definitions [≥15% reduction left ventricular end systolic volume (LVESV) and ≥5% improvement left ventricular ejection fraction] and the most accurate cut‐off for the amount of reverse remodelling that predicted endpoint freedom were assessed. Mean follow‐up was 3.8 ± 2.4 years. ICM was present in 47%. ICM patients who were older (69 ± 7 vs. 63 ± 11), more often men (83% vs. 58%), exhibited less LVESV reduction (13 ± 31% vs. 23 ± 32%) and less left ventricular ejection fraction improvement (5 ± 11% vs. 10 ± 12%) than NIDCM patients (all P < 0.001). Nevertheless, every 1% LVESV reduction was associated with a relative reduction in endpoint occurrence: NIDCM 1.3%, ICM 0.9%, and absolute risk reduction was similar (0.4%). The most accurate cut‐off of LVESV reduction that predicted endpoint freedom was 17.1% in NIDCM and 13.2% in ICM. Conclusions ICM patients achieve less reverse remodelling than NIDCM, but the prognostic gain in terms of survival time is the same for every single percentage of reverse remodelling that does occur. The assessment and expected magnitude of reverse remodelling should take this effect of heart failure aetiology into account.
first_indexed 2024-12-20T23:13:37Z
format Article
id doaj.art-a4eca2fb28834df986bc7cd6d0acbb3c
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-12-20T23:13:37Z
publishDate 2020-04-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-a4eca2fb28834df986bc7cd6d0acbb3c2022-12-21T19:23:40ZengWileyESC Heart Failure2055-58222020-04-017264565310.1002/ehf2.12624Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapyMariëlle Kloosterman0Antonius M.W. vanStipdonk1Iris terHorst2Michiel Rienstra3Isabelle C. Van Gelder4Marc A. Vos5Frits W. Prinzen6Matthias Meine7Kevin Vernooy8Alexander H. Maass9Department of Cardiology University of Groningen, University Medical Centre Groningen PO Box 30.001 Groningen 9700 RB The NetherlandsDepartment of Cardiology Maastricht University Medical Center Maastricht the NetherlandsDepartment of Cardiology University Medical Center Utrecht Utrecht the NetherlandsDepartment of Cardiology University of Groningen, University Medical Centre Groningen PO Box 30.001 Groningen 9700 RB The NetherlandsDepartment of Cardiology University of Groningen, University Medical Centre Groningen PO Box 30.001 Groningen 9700 RB The NetherlandsDepartment of Medical Physiology University Medical Center Utrecht Utrecht the NetherlandsDepartment of Physiology, Cardiovascular Research Institute Maastricht (CARIM) University of Maastricht Maastricht the NetherlandsDepartment of Cardiology University Medical Center Utrecht Utrecht the NetherlandsDepartment of Cardiology Maastricht University Medical Center Maastricht the NetherlandsDepartment of Cardiology University of Groningen, University Medical Centre Groningen PO Box 30.001 Groningen 9700 RB The NetherlandsAbstract Aims Echocardiographic response after cardiac resynchronization therapy (CRT) is often lesser in ischaemic cardiomyopathy (ICM) than non‐ischaemic dilated cardiomyopathy (NIDCM) patients. We assessed the association of heart failure aetiology on the amount of reverse remodelling and outcome of CRT. Methods and results Nine hundred twenty‐eight CRT patients were retrospectively included. Reverse remodelling and endpoint occurrence (all‐cause mortality, heart transplantation, or left ventricular assist device implantation) was assessed. Two response definitions [≥15% reduction left ventricular end systolic volume (LVESV) and ≥5% improvement left ventricular ejection fraction] and the most accurate cut‐off for the amount of reverse remodelling that predicted endpoint freedom were assessed. Mean follow‐up was 3.8 ± 2.4 years. ICM was present in 47%. ICM patients who were older (69 ± 7 vs. 63 ± 11), more often men (83% vs. 58%), exhibited less LVESV reduction (13 ± 31% vs. 23 ± 32%) and less left ventricular ejection fraction improvement (5 ± 11% vs. 10 ± 12%) than NIDCM patients (all P < 0.001). Nevertheless, every 1% LVESV reduction was associated with a relative reduction in endpoint occurrence: NIDCM 1.3%, ICM 0.9%, and absolute risk reduction was similar (0.4%). The most accurate cut‐off of LVESV reduction that predicted endpoint freedom was 17.1% in NIDCM and 13.2% in ICM. Conclusions ICM patients achieve less reverse remodelling than NIDCM, but the prognostic gain in terms of survival time is the same for every single percentage of reverse remodelling that does occur. The assessment and expected magnitude of reverse remodelling should take this effect of heart failure aetiology into account.https://doi.org/10.1002/ehf2.12624Cardiac resynchronization therapyEchocardiographyClinical responseAetiology
spellingShingle Mariëlle Kloosterman
Antonius M.W. vanStipdonk
Iris terHorst
Michiel Rienstra
Isabelle C. Van Gelder
Marc A. Vos
Frits W. Prinzen
Matthias Meine
Kevin Vernooy
Alexander H. Maass
Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy
ESC Heart Failure
Cardiac resynchronization therapy
Echocardiography
Clinical response
Aetiology
title Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy
title_full Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy
title_fullStr Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy
title_full_unstemmed Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy
title_short Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy
title_sort association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy
topic Cardiac resynchronization therapy
Echocardiography
Clinical response
Aetiology
url https://doi.org/10.1002/ehf2.12624
work_keys_str_mv AT mariellekloosterman associationbetweenheartfailureaetiologyandmagnitudeofechocardiographicremodellingandoutcomeofcardiacresynchronizationtherapy
AT antoniusmwvanstipdonk associationbetweenheartfailureaetiologyandmagnitudeofechocardiographicremodellingandoutcomeofcardiacresynchronizationtherapy
AT iristerhorst associationbetweenheartfailureaetiologyandmagnitudeofechocardiographicremodellingandoutcomeofcardiacresynchronizationtherapy
AT michielrienstra associationbetweenheartfailureaetiologyandmagnitudeofechocardiographicremodellingandoutcomeofcardiacresynchronizationtherapy
AT isabellecvangelder associationbetweenheartfailureaetiologyandmagnitudeofechocardiographicremodellingandoutcomeofcardiacresynchronizationtherapy
AT marcavos associationbetweenheartfailureaetiologyandmagnitudeofechocardiographicremodellingandoutcomeofcardiacresynchronizationtherapy
AT fritswprinzen associationbetweenheartfailureaetiologyandmagnitudeofechocardiographicremodellingandoutcomeofcardiacresynchronizationtherapy
AT matthiasmeine associationbetweenheartfailureaetiologyandmagnitudeofechocardiographicremodellingandoutcomeofcardiacresynchronizationtherapy
AT kevinvernooy associationbetweenheartfailureaetiologyandmagnitudeofechocardiographicremodellingandoutcomeofcardiacresynchronizationtherapy
AT alexanderhmaass associationbetweenheartfailureaetiologyandmagnitudeofechocardiographicremodellingandoutcomeofcardiacresynchronizationtherapy